U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.3557G>A (p.Gly1186Asp) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
May 18, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000129855.14

Allele description [Variation Report for NM_000179.3(MSH6):c.3557G>A (p.Gly1186Asp)]

NM_000179.3(MSH6):c.3557G>A (p.Gly1186Asp)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.3557G>A (p.Gly1186Asp)
HGVS:
  • NC_000002.12:g.47805618G>A
  • NG_007111.1:g.27472G>A
  • NG_008397.1:g.105058C>T
  • NM_000179.3:c.3557G>AMANE SELECT
  • NM_001281492.2:c.3167G>A
  • NM_001281493.2:c.2651G>A
  • NM_001281494.2:c.2651G>A
  • NP_000170.1:p.Gly1186Asp
  • NP_000170.1:p.Gly1186Asp
  • NP_001268421.1:p.Gly1056Asp
  • NP_001268422.1:p.Gly884Asp
  • NP_001268423.1:p.Gly884Asp
  • LRG_219t1:c.3557G>A
  • LRG_219:g.27472G>A
  • LRG_219p1:p.Gly1186Asp
  • NC_000002.11:g.48032757G>A
  • NM_000179.2:c.3557G>A
  • p.G1186D
Protein change:
G1056D
Links:
dbSNP: rs587781690
NCBI 1000 Genomes Browser:
rs587781690
Molecular consequence:
  • NM_000179.3:c.3557G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.3167G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.2651G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.2651G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000184672Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(May 18, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV001354496Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 10, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV002528047Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Nov 2, 2021)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Family History of Colorectal or Esophageal Cancer in Barrett's Esophagus and Potentially Explanatory Genetic Variants.

Rubenstein JH, Tavakkoli A, Koeppe E, Ulintz P, Inadomi JM, Morgenstern H, Appelman H, Scheiman JM, Schoenfeld P, Metko V, Stoffel EM.

Clin Transl Gastroenterol. 2020 Apr;11(4):e00151. doi: 10.14309/ctg.0000000000000151.

PubMed [citation]
PMID:
32251017
PMCID:
PMC7263651

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV000184672.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.G1186D variant (also known as c.3557G>A), located in coding exon 7 of the MSH6 gene, results from a G to A substitution at nucleotide position 3557. The glycine at codon 1186 is replaced by aspartic acid, an amino acid with similar properties. This change occurs in the first base pair of coding exon 7. RNA studies have demonstrated that this alteration does not result in abnormal splicing in the set of samples tested (Ambry internal data). This variant was identified in a male proband with Barrett’s esophagus who had a family history of esophageal cancer in a first-degree relative (Rubenstein JH et al. Clin Transl Gastroenterol, 2020 Apr;11:e00151). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV001354496.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This missense variant replaces glycine with aspartic acid at codon 1186 of the MSH6 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with Lynch syndrome or colorectal cancer cancer in the literature. In a large breast cancer case-control study, This variant has been observed in 2/60466 cases and 0/53461 unaffected controls (PMID: 33471991). This variant has been identified in 5/249444 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002528047.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024